Skip to main content
Livermore
Livermore
ZHEN

Geode Capital Management, LLC

SEC CIK
0001214717
Latest filing
Aug 12, 2026

FOLD holding history

Amicus Therapeutics, Inc. in every 13F filed by Geode Capital Management, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

FOLD overviewAll 13F holders of FOLDFull Q2 2026 holdings

Shares (Q2 2026)
0
Sold out in Q2 2026
Value
$0
% of portfolio
0.0%
Quarters held
21
Since Q1 2021
Holdings of FOLD by Geode Capital Management, LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20260$00.0%−8,535,918−100.0%Sold outHolders
Q1 20268,535,918$123.5M<0.1%+1,190,651+16.2%AddedHolders
Q4 20257,345,267$104.6M<0.1%+246,174+3.5%AddedHolders
Q3 20257,099,093$56.0M<0.1%+392,604+5.9%AddedHolders
Q2 20256,706,489$38.4M<0.1%−57,278−0.8%ReducedHolders
Q1 20256,763,767$55.2M<0.1%+152,835+2.3%AddedHolders
Q4 20246,610,932$62.3M<0.1%+11,061+0.2%AddedHolders
Q3 20246,599,871$70.5M<0.1%+80,926+1.2%AddedHolders
Q2 20246,518,945$64.7M<0.1%+308,209+5.0%AddedHolders
Q1 20246,210,736$73.2M<0.1%+259,441+4.4%AddedHolders
Q4 20235,951,295$84.5M<0.1%+345,129+6.2%AddedHolders
Q3 20235,606,166$68.2M<0.1%+210,560+3.9%AddedHolders
Q2 20235,395,606$67.8M<0.1%+253,199+4.9%AddedHolders
Q1 20235,142,407$57.0M<0.1%+251,979+5.2%AddedHolders
Q4 20224,890,428$59.7M<0.1%+167,542+3.5%AddedHolders
Q3 20224,722,886$49.3M<0.1%+63,632+1.4%AddedHolders
Q2 20224,659,254$50.0M<0.1%+143,003+3.2%AddedHolders
Q1 20224,516,251$42.8M<0.1%−210,482−4.5%ReducedHolders
Q4 20214,726,733$54.6M<0.1%+275,911+6.2%AddedHolders
Q3 20214,450,822$42.5M<0.1%−195,109−4.2%ReducedHolders
Q2 20214,645,931$44.8M<0.1%+270,704+6.2%AddedHolders
Q1 20214,375,227$43.2M<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.